LENSAR, Inc.
$5.55
▲
1.51%
2026-04-21 07:56:00
www.lensar.com
NCM: LNSR
Explore LENSAR, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$71.73 M
Current Price
$5.55
52W High / Low
$14.31 / $5.33
Stock P/E
—
Book Value
$-2.17
Dividend Yield
—
ROCE
-79.65%
ROE
-10.69%
Face Value
—
EPS
$-2.87
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
150
Beta
0.98
Debt / Equity
-0.11
Current Ratio
1.15
Quick Ratio
0.62
Forward P/E
-8.03
Price / Sales
1.18
Enterprise Value
$67.49 M
EV / EBITDA
-3.36
EV / Revenue
1.16
Rating
Strong Buy
Target Price
$8.5
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | QT Imaging Holdings, Inc. | $7 | — | $83.45 M | — | -29.28% | 1363.27% | $19.05 / $1.86 | $0.54 |
| 2. | Owlet, Inc. | $5.82 | — | $163.61 M | — | -19.96% | -8.02% | $16.94 / $3.08 | $0.71 |
| 3. | Boston Scientific Corporation | $65.03 | 33.52 | $96.13 B | 0% | 10.39% | 12.45% | $109.5 / $60.59 | $16.34 |
| 4. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
| 5. | Aethlon Medical, Inc. | $2.39 | — | $3.67 M | — | -171.08% | -2.09% | $35.2 / $1.36 | $6.9 |
| 6. | Vivos Therapeutics, Inc. | $1.01 | — | $13.14 M | — | -108.39% | -3.35% | $7.95 / $0.96 | $0.31 |
| 7. | Sera Prognostics, Inc. | $2.29 | — | $90.03 M | — | -46.95% | -51.83% | $4.09 / $1.37 | $1.94 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 16.02 M | 14.32 M | 13.94 M | 14.16 M | 16.73 M | — |
| Operating Profit | -4.92 M | -7.58 M | -6.29 M | -5.79 M | -1.29 M | — |
| Net Profit | -1.46 M | -3.71 M | -1.76 M | -27.34 M | -18.7 M | — |
| EPS in Rs | -0.12 | -0.31 | -0.15 | -2.26 | -1.55 | -0.13 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 58.44 M | 53.49 M | 42.16 M | 35.36 M |
| Operating Profit | -24.58 M | -6.94 M | -12.23 M | -20.18 M |
| Net Profit | -34.28 M | -31.4 M | -14.38 M | -19.91 M |
| EPS in Rs | -2.83 | -2.6 | -1.19 | -1.65 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 71.43 M | 66.3 M | 69.58 M | 55.84 M |
| Total Liabilities | 97.45 M | 61.44 M | 36.16 M | 13.86 M |
| Equity | -26.02 M | 4.86 M | 33.43 M | 41.98 M |
| Current Assets | 46.77 M | 41.98 M | 46.44 M | 33.72 M |
| Current Liabilities | 40.57 M | 15 M | 11.63 M | 11.42 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -14.83 M | -2.27 M | -9.66 M | -14.86 M |
| Investing CF | 1.28 M | -2.16 M | -4.16 M | -0.12 M |
| Financing CF | 10.26 M | 0.08 M | 19.76 M | -1.99 M |
| Free CF | -14.91 M | -2.43 M | -9.89 M | -14.97 M |
| Capex | -0.08 M | -0.16 M | -0.24 M | -0.12 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 26.87% | 19.25% | — | — |
| Earnings Growth % | -118.34% | 27.77% | — | — |
| Profit Margin % | -58.71% | -34.11% | -56.32% | — |
| Operating Margin % | -12.97% | -29% | -57.06% | — |
| Gross Margin % | 48.33% | 50.06% | 56.44% | — |
| EBITDA Margin % | -5.62% | -20.67% | -47.43% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.